<?xml version="1.0" encoding="UTF-8"?>
<p id="par0030">The SARS-CoV-2 primarily infects cells of the small air sacs known as alveoli, consisting of alveolar cells (also known as pneumocytes) and alveolar macrophages. Infection by the SARS-CoV-2 augments inflammatory conditions in the lungs, causing pneumonia with symptoms like dry cough, chest pain, fever, and difficulty in breathing (
 <xref rid="bib0165" ref-type="bibr">Huang et al., 2020</xref>; 
 <xref rid="bib0250" ref-type="bibr">Lescure et al., 2020</xref>). The pneumonic condition in COVID-19 is severe and is associated with its high mortality rate (
 <xref rid="bib0295" ref-type="bibr">Mallapaty, 2020</xref>).
</p>
